| Literature DB >> 25812044 |
Michelle Buehner1, Jeremy Pamplin, Lynette Studer, Rhome L Hughes, Booker T King, John C Graybill, Kevin K Chung.
Abstract
Fluid resuscitation is the foundation of management in burn patients and is the topic of considerable research. One adjunct in burn resuscitation is continuous, high-dose vitamin C (ascorbic acid) infusion, which may reduce fluid requirements and thus decrease the risk for over resuscitation. Research in preclinical studies and clinical trials has shown continuous infusions of high-dose vitamin C to be beneficial with decrease in resuscitative volumes and limited adverse effects. However, high-dose and low-dose vitamin C supplementation has been shown to cause secondary calcium oxalate nephropathy, worsen acute kidney injury, and delay renal recovery in non-burn patients. To the best of our knowledge, the authors present the first case series in burn patients in whom calcium oxalate nephropathy has been identified after high-dose vitamin C therapy.Entities:
Mesh:
Substances:
Year: 2016 PMID: 25812044 PMCID: PMC4933579 DOI: 10.1097/BCR.0000000000000233
Source DB: PubMed Journal: J Burn Care Res ISSN: 1559-047X Impact factor: 1.845
Patient demographics and vitamin C dosages
Figure 1.High power (×40) view of birefringent calcium oxalate crystals with “fan-shaped” morphology.